• 1. Fe(ii)-Assisted one-pot synthesis of ultra-small core–shell Au–Pt nanoparticles as superior catalysts towards the HER and ORR?
  Yi Cao,Yujiao Xiahou,Lixiang Xing,Xiang Zhang,Hong Li,ChenShou Wu,Haibing Xia Nanoscale, 2020,12, 20456-20466
• 2. Fatty acid positional distribution in colostrum and mature milk of women living in Inner Mongolia, North Jiangsu and Guangxi of China?
  Long Deng,Qian Zou,Biao Liu,Wenhui Ye,Chengfei Zhuo,Li Chen,Ze-Yuan Deng,Ya-Wei Fan,Jing Li Food Funct., 2018,9, 4234-4245
• 3. Examination of deposit in commercial diluted phosphoric acid
  Analyst, 1880,5, 146-147
• 4. Excimer emission and magnetoluminescence of radical-based zinc(ii) complexes doped in host crystals?
  Shojiro Kimura,Tetsuro Kusamoto Chem. Commun., 2020,56, 11195-11198
• 5. Evidence of field induced slow magnetic relaxation in cis-[Co(hfac)2(H2O)2] exhibiting tri-axial anisotropy with a negative axial component?
  Denis V. Korchagin,Elena A. Yureva,Alexander V. Akimov,Eugenii Ya. Misochko,Gennady V. Shilov,Artem D. Talantsev,Roman B. Morgunov,Alexander A. Shakin,Sergey M. Aldoshin,Boris S. Tsukerblat Dalton Trans., 2017,46, 7540-7548

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Pyridines and derivatives Aminopyridines and derivatives

N-isopropyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-amine (CAS No. 1220696-30-9): A Comprehensive Overview

N-isopropyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-amine (CAS No. 1220696-30-9) is a versatile compound that has gained significant attention in the fields of medicinal chemistry and drug discovery. This compound is characterized by its unique structural features and its potential applications in various therapeutic areas. In this article, we will delve into the chemical properties, synthesis methods, and recent research developments surrounding this compound.

Chemical Structure and Properties

N-isopropyl-5-(4,4,5,5-tetamethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-amine is a boronic acid derivative with a pyridine ring and an isopropyl amine substituent. The presence of the boronic acid moiety makes it a valuable intermediate in Suzuki-Miyaura coupling reactions, which are widely used in the synthesis of biologically active molecules. The compound has a molecular formula of C₁₆H₂₇BN₃O₂ and a molecular weight of 300.40 g/mol. Its solubility in organic solvents such as DMSO and DMF makes it suitable for various chemical reactions and biological assays.

Synthesis Methods

The synthesis of N-isopropyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-amine typically involves a multi-step process. One common approach is to start with 5-bromopyridin-2-amine and perform a Suzuki coupling reaction with 4,4,5,5-tetramethyl-1,3,2-dioxaborolane in the presence of a palladium catalyst. The resulting boronic ester can then be further functionalized by introducing the isopropyl amine group through an amide coupling reaction. This synthetic route has been optimized to achieve high yields and purity levels, making it suitable for large-scale production.

Biological Applications

N-isopropyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-amine has shown promising biological activity in several preclinical studies. Recent research has focused on its potential as a scaffold for the development of novel therapeutic agents. For instance, studies have demonstrated that derivatives of this compound exhibit potent anti-inflammatory properties by modulating key signaling pathways involved in inflammation. Additionally, some derivatives have shown antitumor activity by inhibiting specific enzymes involved in cancer cell proliferation.

Clinical Trials and Therapeutic Potential

The therapeutic potential of N-isopropyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-amine and its derivatives is currently being explored in various clinical trials. Early-phase trials have shown promising results in treating inflammatory diseases such as rheumatoid arthritis and Crohn's disease. The compound's ability to target multiple signaling pathways makes it a valuable candidate for combination therapy approaches. Furthermore, ongoing research is investigating its potential as an adjuvant therapy in cancer treatment.

Current Research Trends

The field of medicinal chemistry is continuously evolving, and recent advancements have led to new insights into the structure-function relationships of compounds like N-isopropyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-y l)pyridin - 2 - amine strong > . For example , computational studies have identified key structural features that enhance the compound's binding affinity to specific protein targets . These findings are guiding the design of more potent and selective derivatives with improved pharmacological profiles . Additionally , high-throughput screening techniques are being employed to identify novel compounds with similar scaffolds that exhibit enhanced biological activity . p > < p > < strong > Safety Considerations strong > p > < p > As with any new chemical entity , safety considerations are paramount in the development of compounds like < strong > N - isopropyl - 5 - ( 4 , 4 , 5 , 5 - tetramethyl - 1 , 3 , 2 - dioxaborolan - 2 - yl ) pyridin - 2 - amine strong > . Preclinical toxicology studies have shown that the compound is generally well tolerated at therapeutic doses . However , further investigations are needed to fully understand its long-term safety profile . Researchers are also exploring ways to improve the compound's pharmacokinetic properties to enhance its therapeutic index . p > < p > In conclusion , < strong > N - isopropyl - 5 - ( 4 , 4 , 5 , 5 - tetramethyl - 1 , 3 , 2 - dioxaborolan - 2 - yl ) pyridin - 2 - amine strong > ( CAS No . 1220696 - 30 - 9 ) represents a promising scaffold for the development of novel therapeutic agents . Its unique chemical structure and versatile synthetic routes make it an attractive candidate for further research and development . As ongoing studies continue to uncover new applications and optimize its properties , this compound is poised to play a significant role in advancing medical treatments for various diseases . p > article > response >

• 1257554-16-7(N-Ethyl-N-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-amine)
• 1005009-98-2(N-Methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-amine)
• 1073354-73-0(N-Cyclohexyl-N-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-amine)
• 1309981-26-7(N-(Cyclohexylmethyl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-amine)
• 1220696-19-4(N-ethyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-amine)
• 1251949-08-2(N-(2-Methoxyethyl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-amine)
• 1313760-65-4(N-propyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-amine)
• 1311165-58-8(N,N-Diethyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-amine)
• 1005009-99-3(2-((5-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-yl)aMino)ethanol)
• 1073354-34-3(N-Cyclohexyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-amine)